| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $104,602 | 2 | 8 |
Sells | $11,405,812 | 23 | 92 |
| Hackman Jeffrey S. | Chief Executive Officer | 2 | $104,602 | 0 | $0 | $104,602 |
| RALLIS CHRIS A | director | 0 | $0 | 3 | $34,236 | $-34,236 |
| Raykov Rosty | director | 0 | $0 | 13 | $1.03M | $-1.03M |
| Southpoint Capital Advisors LP | 10 percent owner | 0 | $0 | 7 | $10.34M | $-10.34M |
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Over the last 12 months, insiders at Fennec Pharmaceuticals Inc. have bought $104,602 and sold $11.41M worth of Fennec Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at Fennec Pharmaceuticals Inc. have bought $52,301 and sold $4.06M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hackman Jeffrey S. (Chief Executive Officer) — $104,602.
The last purchase of 13,965 shares for transaction amount of $97,615 was made by Hackman Jeffrey S. (Chief Executive Officer) on 2025‑05‑19.
| 2026-01-02 | Sale | Raykov Rosty | director | 10,312 0.0369% | $7.60 | $78,371 | -1.30% | |
| 2025-12-24 | Sale | Southpoint Capital Advisors LP | 10 percent owner | 1M 3.5493% | $7.50 | $7.5M | -0.91% | |
| 2025-12-05 | Sale | Raykov Rosty | director | 10,000 0.0362% | $7.54 | $75,400 | +0.79% | |
| 2025-11-18 | Sale | Southpoint Capital Advisors LP | 10 percent owner | 19,341 0.0705% | $8.79 | $170,048 | -12.69% | |
| 2025-11-17 | Sale | Southpoint Capital Advisors LP | 10 percent owner | 85,918 0.3133% | $8.79 | $755,193 | -12.69% | |
| 2025-11-14 | Sale | Southpoint Capital Advisors LP | 10 percent owner | 160,100 0.606% | $8.00 | $1.28M | -2.67% | |
| 2025-11-05 | Sale | Raykov Rosty | director | 10,000 0.036% | $8.10 | $81,000 | -6.91% | |
| 2025-10-10 | Sale | RALLIS CHRIS A | director | 1,775 0.007% | $9.24 | $16,401 | -9.22% | |
| 2025-10-09 | Sale | Southpoint Capital Advisors LP | 10 percent owner | 20,609 0.0751% | $9.35 | $192,614 | -16.61% | |
| 2025-10-08 | Sale | Southpoint Capital Advisors LP | 10 percent owner | 19,605 0.0733% | $9.47 | $185,722 | -15.62% | |
| 2025-10-07 | Sale | Southpoint Capital Advisors LP | 10 percent owner | 26,900 0.099% | $9.59 | $257,893 | -17.62% | |
| 2025-10-06 | Sale | Raykov Rosty | director | 10,000 0.0365% | $9.78 | $97,800 | -19.51% | |
| 2025-09-04 | Sale | Raykov Rosty | director | 10,000 0.0354% | $8.92 | $89,200 | -11.44% | |
| 2025-08-05 | Sale | Raykov Rosty | director | 10,000 0.0359% | $8.09 | $80,900 | +0.92% | |
| 2025-07-07 | Sale | RALLIS CHRIS A | director | 1,119 0.0042% | $8.71 | $9,746 | -0.83% | |
| 2025-07-03 | Sale | Raykov Rosty | director | 10,000 0.0354% | $8.61 | $86,100 | -4.49% | |
| 2025-06-05 | Sale | Raykov Rosty | director | 10,000 0.0357% | $7.78 | $77,800 | +5.32% | |
| 2025-05-19 | Hackman Jeffrey S. | Chief Executive Officer | 13,965 0.0462% | $6.99 | $97,615 | +8.24% | ||
| 2025-05-16 | Sale | Raykov Rosty | director | 16,667 0.0599% | $6.78 | $113,002 | +21.05% | |
| 2025-05-16 | Hackman Jeffrey S. | Chief Executive Officer | 1,035 0.0037% | $6.75 | $6,986 | +21.05% |
| Southpoint Capital Advisors LP | 10 percent owner | 2744741 9.9629% | $20.83M | 3 | 8 | +14.67% |
| Raykov Rosty | director | 88020 0.3195% | $668,071.80 | 1 | 31 | |
| RALLIS CHRIS A | director | 57079 0.2072% | $433,229.61 | 0 | 15 | |
| Hackman Jeffrey S. | Chief Executive Officer | 15000 0.0544% | $113,850.00 | 2 | 0 | |
| Butts Robert W | 41504000 150.6513% | $315.02M | 1 | 0 | ||
| Essetifin SPA | 10 percent owner | 3993694 14.4963% | $30.31M | 2 | 0 | +12.47% |
| MANCHESTER MANAGEMENT CO LLC | 10 percent owner | 2017357 7.3226% | $15.31M | 42 | 0 | |
| MANCHESTER MANAGEMENT PR, LLC | 10 percent owner | 1250000 4.5373% | $9.49M | 37 | 16 | <0.0001% |
| Andrade Robert | CHIEF FINANCIAL OFFICER | 104271 0.3785% | $791,416.89 | 1 | 10 | |
| Haigh Adrian | CHIEF OPERATING OFFICER | 0 0% | $0 | 0 | 6 |
$22,693,451 | 105 | 8.15% | $196M | |
$7,508,580 | 92 | -5.61% | $217.21M | |
$18,994,888 | 46 | 88.59% | $194M | |
$2,402,219 | 34 | 24.09% | $197.67M | |
$109,415,500 | 33 | 18.13% | $235.33M | |
$1,037,470 | 13 | 78.00% | $207.14M | |
$135,589,307 | 10 | 32.46% | $213.86M | |
$6,847,110 | 9 | 5.96% | $198.17M | |
$13,043,783 | 8 | 732.82% | $211.78M | |
$127,235 | 8 | -12.15% | $238.28M | |
$91,549,696 | 8 | -6.55% | $233M | |
$145,296,407 | 8 | -0.98% | $209.06M | |
$5,905,507 | 7 | 2.69% | $204.48M | |
$119,637,899 | 7 | -18.65% | $222.27M | |
Fennec Pharmaceuticals Inc. (FENC) | $8,286,963 | 6 | 3.09% | $209.1M |
$46,740 | 5 | -73.90% | $247.35M | |
$16,003,671 | 3 | 55.38% | $193.39M | |
$32,289,200 | 3 | -5.46% | $200.84M | |
$802,500 | 1 | 5.37% | $238.06M |
| Increased Positions | 39 | +48.75% | 777,506 | +5.72% |
| Decreased Positions | 29 | -36.25% | 508,529 | -3.74% |
| New Positions | 13 | New | 73,868 | New |
| Sold Out Positions | 5 | Sold Out | 157,326 | Sold Out |
| Total Postitions | 90 | +12.5% | 14M | +1.98% |
| Southpoint Capital Advisors Lp | $31,313.00 | 12.36% | 4.08M | 0 | 0% | 2025-09-30 |
| Solas Capital Management, Llc | $16,803.00 | 6.63% | 2.19M | -45,000 | -2.02% | 2025-09-30 |
| Rosalind Advisors, Inc. | $15,950.00 | 6.29% | 2.08M | +31,196 | +1.52% | 2025-09-30 |
| Blackrock, Inc. | $9,307.00 | 3.67% | 1.21M | -14,631 | -1.19% | 2025-09-30 |
| Vanguard Group Inc | $7,340.00 | 2.9% | 955,764 | -11,328 | -1.17% | 2025-09-30 |
| Aigh Capital Management Llc | $5,234.00 | 2.07% | 681,501 | +229,101 | +50.64% | 2025-09-30 |
| State Street Corp | $2,620.00 | 1.03% | 341,201 | +4,707 | +1.4% | 2025-09-30 |
| Tang Capital Management Llc | $2,570.00 | 1.01% | 334,593 | +314,066 | +1,530.01% | 2025-09-30 |
| Geode Capital Management, Llc | $2,310.00 | 0.91% | 300,772 | -3,825 | -1.26% | 2025-09-30 |
| Morgan Stanley | $1,785.00 | 0.7% | 232,402 | -21,816 | -8.58% | 2025-09-30 |